Valuation (22%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -158.48 | N/A |
| PEG Ratio (TTM) | -2.64 | N/A |
| P/S Ratio (TTM) | 2.79 | N/A |
| P/B Ratio (TTM) | 1.62 | N/A |
| P/FCF Ratio (TTM) | 28.69 | N/A |
| Price to 5YR AVG Earnings Ratio | -1,407.66 | N/A |
| Price to 5YR AVG FCF Ratio | 111.34 | N/A |
Profitability (10%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -0.66% | N/A |
| ROE (TTM) | -1.01% | N/A |
| Net Profit Margin (TTM) | -1.76% | N/A |
| ROIC 5YR AVG | 4.80% | N/A |
Growth (97%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 71.72% | 242.78% | 71.28% |
| Revenue | 4.23% | 31.08% | 27.95% |
| Net Income | 73.49% | 330.39% | 122.33% |
| Cash Flow | 46.96% | 43.57% | 269.95% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.06 | N/A |
| Quick Ratio (TTM) | 0.96 | N/A |
| D/E Ratio (TTM) | 0.15 | N/A |
| Interest Coverage (TTM) | 5.15 | N/A |
| Piotroski F-Score | 4 | N/A |
| Altman Z-Score | 2.13 | N/A |
| LTL to 5YR AVG FCF | 11.17 | N/A |
| Shares Outstanding Growth 5YR AVG | 18.20% | N/A |